The Impact of Adefovior dipivoxil on Th1/Th2 cytokines in chronic hepatitis B Patients
-
摘要: 目的分析细胞因子IFN-γ、TNF-α、IL-10、IL-6、IL-4、IL-2在慢性乙型肝炎患者治疗后血清中的浓度改变及其临床意义。方法应用微阵列流式细胞术(CBA)体外检测慢性乙型肝炎患者治疗前、治疗12周、24周、48周的血清细胞因子IFN-γ、TNF-α、IL-10、IL-6、IL-4、IL-2的浓度。结果慢性乙型肝炎患者阿德福韦酯治疗后外周血清的TH1/TH2细胞因子浓度度,比较治疗前,均是显著升高的(P<0.05),除IL-6外,各细胞因子在治疗过程中均未有显著变化(P>0.05);治疗12周时的血清IL-6的浓度与HBVDNA成负相关,治疗24周,IL-6、IL-10、TNF-α与HBVDNA成负相关(P<0.05)。结论阿德福韦酯除直接抑制病毒作用外,还可能通过免疫调节作用抑制病毒复制。Abstract: Objective To analyze the changes in Th1/Th2 cytokines level in chronic hepatitis B patients during Adefovir dipivoxil therapy.Methods The serum levels of TNF-α, IFN-γ, IL-10, IL-6, IL-4 and IL-2 were measured in chronic hepatitis B (CHB) patients using Cytotoxic Bead Array (CBA) technique.Results After 12, 24, and 48 weeks of treatment, the serum levels of TNF-α, IFN-γ, IL-10, IL-4 and IL-2 in CHB patients were significantly increased compared to the baseline (P < 0.05) .At the 12th week of treatment, IL-6 was negatively correlated with HBV DNA and after 24 weeks of treatment, IL-6, IL-10 and TNF-α were negatively correlated with HBV DNA (P < 0.05) .Conclusion Adefovir dipivoxil may inhibit HBV DNA replication through the immune pathway.
-
Key words:
- Chronic Hepatitis B /
- cytokine /
- Adefovir Dipivoxil /
- Cytotoxic Bead Array
-
[1]Jung MC, Hartmann B, Gerlach JT, et al.Virus-specific lympho-kine production differs quantitatively but not qualitatively in acute and chronic hepatitis B infection[J].Virology, 1999, 261 (2) ∶165-172. [2]Barnaba V, Franco A, Paroli M, et al.Selective expansion of cyto-toxic T lymphocytes with a CD4+CD56+surface phenotype and a T helper type1profile of cytokine secretion in The liver of patients chronically infected with Hepatitis B virus[J].J Immunol, 1994, 15 (6) ∶3074-3087. [3]Raffaele C, Nicoletta V, Emanuela B, et al.Enhancement of natural killer activity and interferon induction by different acyclic nucleoside phosphonates[J].Antivir ResVolume Issue, 1994, 23 (1) ∶77-89. [4]Stoop JN, van der Molen RG., Baan CC, et al.Regulatory T cells contribute to The impaired immune response in patients with chronic hepatitis B virus infection[J].Hepatology, 2005, 41 (4) ∶771-778. [5]EiriniI R, Deepak S, Shilpa C et al.Lamivudine Plus Interleukin-12Combination Therapy in Chronic Hepatitis B:Antiviral and Immuno-logicalActivity[J].Hepatology, 2005, 42 (5) ∶1028-36. [6]江军, 缪晓辉, 蔡雄.阿德福韦酯和拉米夫定对慢性乙型肝炎患者IFN-γ和IL-4的影响比较[J].临床肝胆病杂志.2007, 23 (3) ∶176-178. [7]马萍, 王磊, 王怡, 等.慢性乙型肝炎患者阿德福韦酯治疗前后血清Th1和Th2细胞因子水平变化及其与HBeAg的关系[J].中华实验和临床感染病杂志 (电子版) , 2008, 2 (1) ∶55-58. [8]Jiang YF, Wang F, Liu YY, et al.The host immunity response of hepatitis B patients after Adefovir dipivoxil and Entecavir therapy[J].Hepatology, 2008, 47 (6) ∶1020. [9]Kuo TM, Hu CP, Chen YL, et al.HBV replication is significantly reduced by IL-6[J].Journal of Biomedical Science, 2009, 16 (1) ∶41.
本文二维码
计量
- 文章访问数: 2968
- HTML全文浏览量: 7
- PDF下载量: 640
- 被引次数: 0